Neurological complications of herpes simplex virus type 2 infection

Archives of Neurology

Volumn 65, Issue 5, 2008, Pages 596-600

  Berger, Joseph R ^a,b   Houff, Sidney ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET SODIUM; GLUCOCORTICOID; THYMIDINE KINASE; VALACICLOVIR; VIDARABINE PHOSPHATE; VIRUS DNA;

ACUTE DISEASE; ASEPTIC MENINGITIS; BELL PALSY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NEUROPATHY; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; GENE MUTATION; GENITAL TRACT INFECTION; HERPES SIMPLEX; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; INFECTION RISK; KIRISAWA UVEITIS; MENINGITIS; MENINGOENCEPHALITIS; MORBIDITY; MYELITIS; NEUROLOGIC DISEASE; NEWBORN CARE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADICULITIS; RADICULOPATHY; RECURRENT DISEASE; REVIEW; SEQUENCE HOMOLOGY; SEROPREVALENCE; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS CULTURE; VIRUS RESISTANCE; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MENINGITIS, ASEPTIC; PERIPHERAL NERVOUS SYSTEM DISEASES; RECURRENCE; RETINAL DEGENERATION;

EID: 43549086199     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.5.596     Document Type: Review

References (25)

1. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997;337(16):1105-1111.
2. Mertz GJ. Epidemiology of genital herpes infections. Infect Dis Clin North Am. 1993;7(4):825-839.
3. Whitley R. Neonatal herpes simplex virus infection. Curr Opin Infect Dis. 2004;17(3):243-246.
4. Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet. 1988;1(8575-8576):1-4.
5. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983;98(6):958-972.
6. Calvario A, Bozzi A, Scarasciulli M, et al. Herpes consensus PCR test: a useful diagnostic approach to the screening of viral diseases of the central nervous system. J Clin Virol. 2002;25(suppl 1):S71-S78.
7. Tyler KL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes. 2004;11(suppl 2):57A-64A.
8. Bergström T, Vahlne A, Alestig K, Jeansson S, Forsgren M, Lycke E. Primary and recurrent herpes simplex virus type 2-induced meningitis. J Infect Dis. 1990;162(2):322-330.
9. Afonso N, Gunasena S, Galla K, Podzorski R, Chandrasekar P, Alangaden G. Appropriate use of polymerase chain reaction for detection of herpes simplex virus 2 in cerebrospinal fluid of patients at an inner-city hospital. Diagn Microbiol Infect Dis. 2007;57(3):309-313.
10. Stalder H, Oxman MN, Dawson DM, Levin MJ. Herpes simplex meningitis: isolation of herpes simplex virus type 2 from cerebrospinal fluid. N Engl J Med. 1973;289(24):1296-1298.d
11. Aurelius E, Johansson B, Skoldenberg B, Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol. 1993;39(3):179-186.
12. Chu K, Kang DW, Lee JJ, Yoon BW. Atypical brainstem encephalitis caused by herpes simplex virus 2. Arch Neurol. 2002;59(3):460-463.
13. Harrison NA, MacDonald BK, Scott G, Kapoor R. Atypical herpes type 2 encephalitis associated with normal MRI imaging. J Neurol Neurosurg Psychiatry. 2003;74(7):974-976.
14. Gobbi C, Tosi C, Stadler C, Merenda C, Bernasconi E. Recurrent myelitis associated with herpes simplex virus type 2. Eur Neurol. 2001;46(4):215-218.
15. Eberhardt O, Kuker W, Dichgans J, Weller M. HSV-2 sacral radiculitis (Elsberg syndrome). Neurology. 2004;63(4):758-759.
16. Ellie E, Rozenberg F, Dousset V, Beylot-Barry M. Herpes simplex virus type 2 ascending myeloradiculitis: MRI findings and rapid diagnosis by the polymerase chain method. J Neurol Neurosurg Psychiatry. 1994;57(7):869-870.
17. Küker W, Schaade L, Ritter K, Nacimiento W. MRI nfi1follow-up of herpes simplex virus (type 1) radiculomyelitis. Neurology. 1999;52(5):1102-1103.
18. Gilbert SC. Bell's palsy and herpesviruses. Herpes. 2002;9(3):70-73.
19. Wald A, Ericsson M, Krantz E, Selke S, Corey L. Oral shedding of herpes simplex virus type 2. Sex Transm Infect. 2004;80(4):272-276.
20. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35(5):435-445.
21. Nagot N, Ouedraogo A, Foulongne V, et al; ANRS 1285 Study Group. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007;356(8):790-799.
22. Corey L. Synergistic copathogens: HIV-1 and HSV-2. N Engl J Med. 2007;356(8):854-856.
23. Kimberlin DW, Lin CY, Jacobs RF, et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108(2):223-229.
24. Sköldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis: randomised multicentre study in consecutive Swedish patients. Lancet. 1984;2(8405):707-711.
25. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314(3):144-149.